• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    5.97 Up 0.05(0.84%) Dec 19, 4:00PM EST
    |After Hours : 5.97 Up 0.00 (0.07%) Dec 19, 5:35PM EST
    Add to Portfolio
    Prev Close:5.92
    Open:5.91
    Bid:N/A
    Ask:26.45 x 5800
    1y Target Est:10.07
    Beta:1.51
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:5.83 - 6.08
    52wk Range:3.34 - 6.95
    Volume:5,875,278
    Avg Vol (3m):4,032,490
    Market Cap:1.42B
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXUp 0.84%1.42B
    MRKUp 1.02%169.86B
    NVSUp 0.04%228.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):43.19
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.32
    Quarterly EPS Est (Dec-14) :-0.08
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback